Article
COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing.
Biochemical Society transactions - 1 Apr 2009
Li Jin, Makrigiorgos G Mike
Abstract excerpt
PCR is widely employed as the initial DNA amplification step for genetic testing and cancer biomarker detection. However, a key limitation of PCR-based methods, including real-time PCR, is the inability to selectively amplify low levels of variant alleles in a wild-type allele background. As a result, downstream assays are limited in their ability to identify subtle genetic changes that can have a profound impact...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
